European Journal of Organic Chemistry
10.1002/ejoc.201600952
FULL PAPER
Hz, 1 H, Hb-6), 3.97 (ddd, J = 5.3, 3.8, 1.3 Hz, 1 H, H-3), 3.61 (s, 3 H,
OMe), 2.70 – 2.31 (m, 3 H, CH2-CO2Me + CH2a-C(3)), 2.16 – 1.94 (m, 1
H, CH2b-C(3)), 0.92 (s, 9 H, t-BuSi), 0.90 (s, 9H t-BuSi), 0.16 (s, 3 H,
MeSi), 0.16 (s, 3 H, MeSi), 0.15 (s, 3 H, MeSi), 0.14 (s, 3 H, MeSi). 13C
NMR (101 MHz, CDCl3): δ = 174.0 (C–13), 164.3 (C=O), 159.6 (C-5),
147.8 (C-NO2), 143.7 (C(pNB)), 128.7 (CH(pNB)), 123.9 (CH(pNB)),
108.4 (C-4), 68.3 (C-6), 64.5 (CH2(pNB)), 64.5 (C-3), 51.5 (OMe), 32.9
(CH2-CO2Me), 26.1 (Me3CSi), 25.7 (Me3CSi), 23.9 (CH2-C(3)), 18.6
(Me3CSi), 18.0 (Me3CSi), –3.6 (Me2Si), –5.2 (Me2Si). 29Si NMR (60 MHz,
CDCl3): δ = 28.03, 24.43. 15N NMR (30 MHz, CDCl3, from {1H–
15N}HMBC) δ = 369 (NO2), 245 (N–OTBS). Elem. anal. calcd. for
C28H46N2O9Si2: C, 55.06; H, 7.59; N, 4.59; Si, 9.20. Found: C, 55.08; H,
7.56; N, 4.60; Si, 9.18.
Hz, 1 H, CH2a(pNB)), 4.47-4.53 (m, 1 H, H-3), 4.42 (dd, J = 15.9, 1.4 Hz,
1 H, Ha-6), 4.39 (d, J = 13.5, 1 H, CH2b(pNB)), 3.98 (d, J = 15.9 Hz, 1 H,
Hb-6), 3.83 (dd, J = 14.0, 4.6 Hz, 1 H, CH2a–C(3)), 3.33 (s, 3 H, OMe),
3.10 (dd, J = 14.0, 6.5 Hz, 1 H, CH2b–C(3)), 0.97 (s, 9 H, t-BuSi), 0.86 (s,
9 H, t-BuSi), 0.25 (s, 3 H, MeSi), 0.19 (s, 3 H, MeSi), 0.13 (s, 3 H, MeSi),
0.09 (s, 3 H, MeSi). 13C NMR (50 MHz, toluene-d8): δ = 163.3 (C=O),
158.2 and 158.0 (C-5 and C(PMP)), 147.4 (C-NO2), 142.9 (C(pNB)),
132.0 (C(PMP)), 130.7 (CH(PMP)), 128.1 (CH(pNB)), 127.9 (CH(pNB)),
123.0 (CH(PMP)), 110.0 (C-4), 68.7, 67.2 and 63.9 (C-3, C-6 and
CH2(pNB)), 54.3 (OMe), 33.9 (CH2-C(3)), 25.7 (Me3CSi), 25.4 (Me3CSi),
18.2 (Me3CSi), 17.8 (Me3CSi), -4.2 (MeSi), -4.3 (MeSi), –5.3 (MeSi), –5.5
(MeSi). 15N NMR (30 MHz, toluene-d8, from {1H–15N}HMBC) δ = 244 (N–
OTBS). Signal of NO2 was not observed due to broadening and low
intensity. Elem. anal. calcd. for C32H48N2O8Si2: C, 59.60; H, 7.50; N, 4.34;
Si, 8.71. Found: C, 59.85; H, 7.51; N, 4.28; Si, 8.52.
4-nitrobenzyl
2,5-bis((tert-butyldimethylsilyl)oxy)-3-phenethyl-3,6-
dihydro-2H-1,2-oxazine-4-carboxylate (3ga)
4-nitrobenzyl 2,5-bis((tert-butyldimethylsilyl)oxy)-3,3-dimethyl-3,6-
dihydro-2H-1,2-oxazine-4-carboxylate (3ia)
Obtained according to general procedure from nitronate 1g (276 mg, 1.0
mmol) and diazo compound 2a (377 mg, 1.0 mmol). Yield: 461 mg
(73 %), colorless oil. Rf (SiO2, 3:1 PE–EtOAc): 0.51. H NMR (300 MHz,
1
Obtained according to general procedure from nitronate 1i (203 mg, 1.0
mmol) and diazo compound 2a (377 mg, 1.0 mmol). Yield: 375 mg
(68 %), colorless oil. Crystallized spontaneously upon storage at 4 °C.
mp 50–53 °C (not recrystallized). Rf (SiO2, 3:1 PE–EtOAc): 0.60. 1H NMR
(400 MHz, CDCl3): δ = 8.21 (d, J = 8.8 Hz, 2 H, CH(pNB)), 7.53 (d, J =
8.8 Hz, 2 H, CH(pNB)), 5.30 (d, J = 13.5 Hz, 1 H, CH2a(pNB)), 5.23 (d, J
= 13.4 Hz, 1 H, CH2b(pNB)), 4.21 (d, J = 15.5 Hz, 1 H, Ha-6), 3.91 (br d, J
= 15.6 Hz, 1 H, Hb-6), 1.36 (s, 3 H, Me-3), 1.23 (s, 3 H, Me-3), 0.92 (s, 9
H, t-BuSi), 0.89 (s, 9 H, t-BuSi), 0.19 (s, 6 H, Me2Si), 0.15 (s, 6 H, Me2Si).
13C NMR (101 MHz, CDCl3): δ = 166.0 (C=O), 151.2 (C-5), 147.8 (C-
NO2), 143.6 (C(pNB)), 128.6 (CH(pNB)), 123.9 (CH(pNB)), 112.6 (br, C-
4), 65.2 (C-3), 64.6 (CH2(pNB)), 61.5 (br, C-6), 27.3 (Me-3), 26.1
(Me3CSi), 25.7 (Me3CSi), 22.5 (Me-3), 18.4 (Me3CSi), 18.0 (Me3CSi), –
3.83 (Me2Si), –4.77 (Me2Si). 29Si NMR (60 MHz, CDCl3): δ = 27.1, 23.7.
15N NMR (30 MHz, CDCl3, from {1H–15N}HMBC) δ = 240 (N–OTBS).
HRMS (ESI) m/z calcd. for [C26H44N2O7Si2 + H+]: 553.2760, found:
553.2760.
CDCl3): δ = 8.18 (d, J = 8.8 Hz, 2 H, CH(pNB)), 7.49 (d, J = 8.8 Hz, 2 H,
CH(pNB)), 7.25 – 7.06 (m, 5 H, Ph), 5.30 (d, J = 13.3 Hz, 1 H,
CH2a(pNB)), 5.21 (d, J = 13.3 Hz, 1 H, CH2b(pNB)), 4.33 (dd, J = 15.9,
1.6 Hz, 1 H, Ha-6), 4.07 (dd, J = 15.9, 0.7 Hz, 1 H, Hb-6), 4.05 – 4.00 (m,
1 H, H-3), 2.87 (ddd, J = 13.5, 11.5, 5.3 Hz, 1 H, CH2a–Ph), 2.77 – 2.63
(m, 1 H, CH2a–Ph), 2.51 (ddt, J = 14.2, 11.4, 5.7 Hz, 1 H, CH2a–C(3)),
1.88 (dddd, J = 14.2, 11.6, 5.4, 3.8 Hz, 1 H, CH2b–C(3)), 0.96 (s, 9 H, t-
BuSi), 0.93 (s, 9 H, t-BuSi), 0.20 (s, 3 H, MeSi), 0.19 (s, 3 H, MeSi), 0.18
(s, 3 H, MeSi), 0.18 (s, 3 H, MeSi). 13C NMR (75 MHz, CDCl3): δ = 164.5
(C=O), 158.8 (C-5), 147.8 (C-NO2), 143.7 (C(pNB)), 142.8 (CPh), 128.9
(CH(pNB)), 128.8 (CHm-Ph), 128.6 (CHp-Ph), 125.8 (CHo-Ph), 123.9
(CH(pNB)), 109.3 (C-4), 68.1 (C-6), 65.2 (C-3), 64.4 (CH2(pNB)), 34.9
(CH2–Ph), 30.8 (CH2–C(3)), 26.2 (Me3CSi), 25.8 (Me3CSi), 18.6 (Me3CSi),
18.0 (Me3CSi), –3.69 (MeSi), –4.97 (MeSi), –5.09 (MeSi). 29Si NMR (60
MHz, CDCl3): δ = 27.7, 24.3. 15N NMR (30 MHz, CDCl3, from {1H–
15N}HMBC) δ = 369 (NO2), 245 (N–OTBS). HRMS (ESI) m/z calcd. for
C32H49N2O7Si2: 629.3073, found: 629.3071.
4-nitrobenzyl
1,4-bis((tert-butyldimethylsilyl)oxy)-2-oxa-1-
4-nitrobenzyl
rel-(2R,3R)-2,5-bis((tert-butyldimethylsilyl)oxy)-3-(4-
azaspiro[5.5]undec-4-ene-5-carboxylate (3ja)
methoxybenzyl)-3,6-dihydro-2H-1,2-oxazine-4-carboxylate (3ha)
Obtained according to general procedure from nitronate 1j (243 mg, 1.0
mmol) and diazo compound 2a (377 mg, 1.0 mmol). Title compound
crystallized spontaneously upon storage. Yield: 400 mg (67 %), white
solid. mp 51–53 °C (not recrystallized). Rf (SiO2, 3:1 PE–EtOAc): 0.57.
1H NMR (300 MHz, CDCl3): δ = 8.21 (d, J = 8.8 Hz, 2 H, CH(pNB)), 7.54
(d, J = 8.7 Hz, 2 H, CH(pNB)), 5.32 (d, J = 13.6 Hz, 1 H, CH2a(pNB)),
5.20 (d, J = 13.6 Hz, 1 H, CH2b(pNB)), 4.18 (d, J = 15.4 Hz, 1 H, Ha-6),
3.73 (d, J = 15.4 Hz, 1 H, Hb-6), 1.97 – 1.02 (m, 10 H, CH2(c-Hex)), 0.92
(s, 9 H, t-BuSi), 0.87 (s, 9 H, t-BuSi), 0.24 (s, 3 H, MeSi), 0.21 (s, 3 H,
MeSi), 0.13 (s, 3H, MeSi), 0.13 (s, 3H, MeSi). 13C NMR (75 MHz, CDCl3):
δ = 167.0 (C=O), 147.8 (C-5), 147.7 (C-NO2), 143.5 (C(pNB)), 128.5
(CH(pNB)), 123.8 (CH(pNB)), 113.0 (C-4), 66.7 (C-3), 64.8 (CH2(pNB)),
59.0 (C-6), 36.6 (CH2-C(3)), 31.4 (CH2-C(3)), 26.1 (Me3CSi), 25.7
(Me3CSi), 21.8 (CH2), 21.4 (CH2), 18.2 (Me3CSi), –3.8 (MeSi), –4.1
(MeSi), –4.9 (MeSi). 29Si NMR (60 MHz, CDCl3): δ = 27.8, 23.3. 15N NMR
(30 MHz, CDCl3, from {1H–15N}HMBC) δ = 235 (N–OTBS). Elem. anal.
calcd. for C29H48N2O7Si2: C, 58.75; H, 8.16; N, 4.73; Si, 9.47. Found: C,
58.70; H, 8.17; N, 4.72; Si, 9.36.
Obtained by a modified general procedure: solution of nitronate 1h (590
mg, 2.0 mmol) and diazo compound 2a (1131 mg, 3.0 mmol) in CH2Cl2 (4
mL) was added dropwise during 15 min. to the stirring suspension of
Rh2(OAc)4 (18 mg, 0.04 mmol) in CH2Cl2 (1 mL). Title compound was
recrystallized from methanol (10 mL). Yield: 897 mg (70 %), off-white
prisms. mp 95–97 °C (methanol). Rf (SiO2, 3:1 PE–EtOAc): 0.50. 1H
NMR (400 MHz, CDCl3): δ = 8.15 (d, J = 8.7 Hz, 2 H, CH(pNB)), 7.32 (d,
J = 8.7 Hz, 2 H, CH(pNB)), 7.08 (d, J = 8.5 Hz, 2 H, CH(PMP)), 6.68 (d, J
= 8.6 Hz, 2 H, CH(PMP)), 5.04 (d, J = 13.6 Hz, 1 H, CH2a(pNB)), 4.66 (d,
J = 13.6 Hz, 1 H, CH2b(pNB)), 4.37 (dd, J = 15.9, 1.5 Hz, 1 H, Ha-6), 4.20
(ddd, J = 6.6, 4.8, 1.4 Hz, 1 H, H-3), 4.08 (d, J = 15.9 Hz, 1 H, Hb-6), 3.71
(s, 3 H, OMe), 3.57 (dd, J = 13.9, 4.8 Hz, 1 H, CH2a–C(3)), 2.85 (dd, J =
13.9, 7.0 Hz, 1 H, CH2b–C(3)), 0.91 (s, 9 H, t-BuSi), 0.90 (s, 9 H, t-BuSi),
0.16 (s, 6 H, Me2Si), 0.15 (s, 3 H, MeSi), 0.14 (s, 3 H, MeSi). 13C NMR
(101 MHz, CDCl3): δ = 164.1 (C=O), 158.4 (C-5), 157.9 (C(PMP)), 147.7
(C-NO2), 143.6 (C(pNB)), 132.2 (C(PMP)), 130.7 (CH(PMP)), 128.4
(CH(pNB)), 123.7 (CH(pNB)), 113.6 (CH(PMP)), 109.9 (C-4), 68.9 (C-6),
67.1 (C-3), 64.4 (CH2(pNB)), 55.3 (OMe), 33.6 (CH2-C(3)), 26.1 (Me3CSi),
25.7 (Me3CSi), 18.5 (Me3CSi), 18.0 (Me3CSi), –3.7 (MeSi), –5.0 (MeSi), –
5.2 (MeSi). 29Si NMR (60 MHz, CDCl3): δ = 27.8, 24.4. 15N NMR (30 MHz,
CDCl3, from {1H–15N}HMBC) δ = 369 (NO2), 244 (N–OTBS). 1H NMR
(200 MHz, toluene-d8): δ = 7.73 (d, J = 8.5 Hz, 2 H), 7.15 (d, J = 8.3 Hz,
2 H), 6.72 (d, J = 8.5 Hz, 2 H), 6.62 (d, J = 8.2 Hz, 2 H), 4.94 (d, J = 13.5
4-nitrobenzyl
(2R*,3S*)-1-((tert-butyldimethylsilyl)oxy)-2-(2-((tert-
butyldimethylsilyl)oxy)-2-oxoethyl)-3-methylaziridine-2-carboxylate
(4)
This article is protected by copyright. All rights reserved